San Francisco, California
Phase 1 colorectal cancer trials in San Francisco, CA
16 Phase 1 colorectal cancer studies are recruiting participants at sites in San Francisco as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
San Francisco at a glance
- 16 studies are recruiting at a site in San Francisco.
- By phase: Phase 1 (8), Phase 1/2 (8).
- By sponsor: industry (14), university, hospital or other (2).
- Most recent update to one of these records: November 17, 2026.
Studies recruiting in San Francisco
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Institut de Recherches Internationales Servier
- Study site
- University of California, San Francisco (UCSF)
- Registry record
- NCT05786924 · updated
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- UCSF Helen Diller Family Comprehensive Cancer Center
- Registry record
- NCT07397338 · updated
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Relay Therapeutics, Inc.
- Study site
- University of California, San Francisco
- Registry record
- NCT07584226 · updated
LYL273 for Patients With Relapsed or Refractory mCRC
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Lyell Immunopharma, Inc.
- Study site
- University of California San Francisco Medical Center
- Registry record
- NCT05319314 · updated
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Parabilis Medicines, Inc.
- Study site
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center
- Registry record
- NCT05919264 · updated
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- EvolveImmune United, Inc
- Study site
- UCSF Medical center Parnassus
- Registry record
- NCT07217171 · updated
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Phase 1
- Ages 12 to 85
- All sexes
- Sponsor
- Inhibrx Biosciences, Inc
- Study site
- University of California, San Francisco (UCSF)
- Registry record
- NCT03715933 · updated
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Cartography Biosciences
- Registry record
- NCT07321106 · updated
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Phase 1/2
- From 12 months, up to 30 years
- All sexes
- Sponsor
- Children's Oncology Group
- Study site
- UCSF Medical Center-Mission Bay
- Registry record
- NCT04851119 · updated
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- ArriVent BioPharma, Inc.
- Registry record
- NCT07066657 · updated
A Study of DM002 in Patients With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
- Study site
- University of California San Francisco Cancer Center
- Registry record
- NCT06751329 · updated
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
- Study site
- University of California San Francisco Helen Diller Family Comprehensive Cancer Center
- Registry record
- NCT06917079 · updated
A Study of MGC028 in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- MacroGenics
- Study site
- UCSF - Helen Diller Family Cancer Center
- Registry record
- NCT06723236 · updated
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- MBrace Therapeutics
- Study site
- UCSF Helen Diller Family Comprehensive Cancer Center
- Registry record
- NCT07145255 · updated
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Clasp Therapeutics, Inc.
- Study site
- University of California San Francisco
- Registry record
- NCT06778863 · updated
A Study of NX-1607 in Adults With Advanced Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Nurix Therapeutics, Inc.
- Study site
- University of California, San Francisco
- Registry record
- NCT05107674 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in San Francisco, CA on ClinicalTrials.gov.
Ask about studies near San Francisco
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in California
All California locations
96 studies recruiting across 22 cities.
Los Angeles
58 studies recruiting.
Duarte
25 studies recruiting.
Orange
13 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections